Member Info for flava

Market makers went after stop losses and picked up cheap shares for a push upwards very soon.

Wow, I think this is going to break the LSE record. Damn, I sold too early! I think this will hit 7p today.

I have taken a large chunk under 4.40p, can not believe pi was paid 8p yesterday, and currently the discount rate is good for buying. It is a no-brainer to add some now for huge upside potential when the revised bid is announced. Good luck all and do your own research.

I have taken my profits and thanks for the nice ride. Goodluck all

I would just ignore the trolls aka shorters here. They want to publish incorrect information so they can close their shorts before the big offer news lands. I don't like to mention names here, but you all guess it by now who's actively posting utter nonsense.

Https://www.msn.com/en-gb/money/other/us-oil-giant-chevron-agrees-53-billion-dollar-deal-to-buy-hess/ar-AA1iH9oP?rc=1&ocid=winp1taskbar&cvid=3241433ef9ca4475efff9f41409cfd0e&ei=9

Chevron is buying Hess for $53 billion to increase its oil and gas production and reserves. Hess has a major oil field in Guyana and shale sites in the Bakken Formation in North Dakota.

The deal is also a sign that Chevron is betting on continued fossil-fuel use. Despite the growing pressure to transition to clean energy, Chevron is still investing billions of dollars in new oil and gas projects.

UPL's 14p takeover offer was rejected by BoD, and I'm guessing they're looking in the region of 25p-30p for a sale.

I believe that nasal photodisinfection has the potential to revolutionise the way we prevent surgical site infections. I am excited to see how this technology is adopted and used in the future.

I think the results of this study are very impressive. A 66.5% reduction in surgical site infection rate is a significant improvement. The fact that nasal photodisinfection is also safe and cost-effective makes it a very attractive option for hospitals and patients alike.

I am particularly interested in the fact that nasal photodisinfection does not generate resistance to antibiotics. This is important because the overuse of antibiotics is a major contributor to the rise of antibiotic-resistant bacteria.

The impact of nasal photodisinfection on spine surgery infection rate:

> 66.5% reduction in surgical site infection rate in spine patients

> $19.9 million net cost savings over the 8-year study period between 2011 and 2019 from reduced infection rates.

> Demonstration of long-term safety - no complications or adverse events specific to the administration of nasal photodisinfection.

Steriwave® photodisinfection could be used to generate revenue:

✅ Sale of Steriwave® photodisinfection devices to hospitals and other healthcare facilities

✅ Sale of Steriwave® photodisinfection treatments to patients

✅ Licensing of Steriwave® photodisinfection technology to other companies

✅ Development of new Steriwave® photodisinfection products and services

The potential value of Steriwave® photodisinfection is difficult to estimate, but it has the potential to be a multi-billion dollar market. The global market for infection prevention and control is estimated to be worth over $100 billion, and the market for antibiotic resistance solutions is estimated to be worth over $20 billion. Steriwave® photodisinfection could address both of these markets.

In addition to the direct market for Steriwave® photodisinfection, the technology also has the potential to generate significant cost savings. For example, a study published in the Journal of Hospital Infection found that Steriwave® photodisinfection reduced the rate of surgical site infections by 78%. This could lead to significant savings in hospital costs, as surgical site infections are a major cause of hospital readmissions.

Overall, the potential value of Steriwave® photodisinfection is significant. The technology has the potential to address a major public health threat and to generate significant cost savings. If Steriwave® photodisinfection can be proven to be safe and effective in clinical trials, it could be a valuable tool in the fight against antibiotic resistance.

Climbing again

Steriwave® photodisinfection works by using a photosensitizer and a specific wavelength of light to produce reactive oxygen species (ROS). ROS are highly reactive molecules that can damage bacteria. The photosensitizer is taken up by the bacteria, and when it is exposed to light, it produces ROS that kill the bacteria.

That is indeed impressive news! Steriwave® photodisinfection is a promising new technology that has the potential to help combat the growing problem of antibiotic resistance. The fact that it was able to reduce antibiotic-resistant bacteria by more than 99.9% is a significant achievement.

Antibiotic resistance is a major public health threat. It occurs when bacteria develop the ability to resist the effects of antibiotics. This can make it difficult or impossible to treat infections caused by these bacteria. Antibiotic-resistant infections are becoming more common, and they are responsible for a significant number of deaths each year.

That is indeed impressive news! Steriwave® photodisinfection is a promising new technology that has the potential to help combat the growing problem of antibiotic resistance. The fact that it was able to reduce antibiotic-resistant bacteria by more than 99.9% is a significant achievement.

This is the golden goose - don't miss this opportunity for massive gains..

You've been warned.

I have reported you now.

Someone increasing their holding.

Easy bagger for anyone with commonsense.

Wadogara - Jealousy kicks in when others miss the boat or didn't bother taking that chance. It's a natural human reaction to see others making money, especially when one's own investments are not performing well. This is often the case with people who have held onto shares for a long time without seeing any movement. When they see other shares moving quickly, it can be easy to feel envious. It's always important to do your own research and make investment decisions based on your own individual circumstances.

Trolls, It's more likely that people who are envious are simply feeling frustrated with their own investment performance. If you find yourself feeling envious of others, it can be helpful to focus on your own goals and to remember that everyone's investment journey is different.